Breakthroughs in Genetic Life Extension – David Ewing Duncan


Could future advances in nanomedicine bring a breakthrough in genetic life extension?

In 2008, pharmaceutical giant GlaxoSmithKline announced that it would acquire all outstanding shares of Sirtris Pharmaceuticals for $720 million in order to cash in on the life-extending promise of resveratrol-based compounds, found in redgrapes and wine, which have been credited with extending life span. This thing is on clinical trial and various projects of similar intent are being conducted. I would recommend Dr. David Ewing Duncan’s statement on this futuristic breakthrough expected to materialise in the next 10 yrs but still with the likelihood of failure. The trial has shown encouraging signs on various experiments including one on mice, with high efficacy in slowing down the rate we age.

Complete video at: http://fora.tv/2008/07/15/Creative_Disruptions_David_Ewing_Duncan David Ewing Duncan, co-host of NPR\’s \

via YouTube – Breakthroughs in Genetic Life Extension – David Ewing Duncan.

This entry was posted in Medical breakthroughs, Medical knowledgebase. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s